Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD
Jun 30, 2025•10 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic drinking?
Faculty: David Gorelick, M.D.
Host: Richard Seeber, M.D.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast